AVITA Medical, Inc. (RCEL) — insider trading
Health Care · NASDAQ
AVITA Medical, Inc. (RCEL) has 31 reported SEC Form 4 insider transactions in our data, including 12 open-market purchases among the most recent 31 (latest 2026-06-12).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | O'Toole David D | Officer (CFO) | Open-market purchase | 2,000 | $3.97 | $7.9K | Form 4/A |
| 2026-06-12 | O'Toole David D | Officer (CFO) | Grant / award / vesting | 2,000 | $3.97 | $7.9K | Form 4 |
| 2026-06-09 | Woody Joseph Fralin | Director | Open-market purchase | 5,200 | $4.00 | $20.8K | Form 4 |
| 2026-06-09 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.18 | $20.9K | Form 4 |
| 2026-06-09 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.20 | $21.0K | Form 4 |
| 2026-06-03 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.09 | $20.4K | Form 4 |
| 2026-06-03 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.10 | $20.5K | Form 4 |
| 2026-06-02 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.21 | $21.0K | Form 4 |
| 2026-06-02 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.18 | $20.9K | Form 4 |
| 2026-06-01 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.26 | $21.3K | Form 4 |
| 2026-06-01 | Woody Joseph Fralin | Director | Open-market purchase | 5,000 | $4.34 | $21.7K | Form 4 |
| 2026-05-29 | Vance Cary Guy | Director, Officer (President and CEO) | Grant / award / vesting | 5,000 | $3.05 | $15.3K | Form 4 |
| 2026-05-29 | O'Toole David D | Officer (CFO) | Grant / award / vesting | 5,000 | $3.05 | $15.3K | Form 4 |
| 2026-05-20 | O'Toole David D | Officer (CFO) | Open-market purchase | 2,000 | $4.26 | $8.5K | Form 4 |
| 2026-05-19 | O'Toole David D | Officer (CFO) | Open-market purchase | 2,000 | $4.24 | $8.5K | Form 4 |
| 2026-01-20 | REED JAN STERN | Director | Grant / award / vesting (derivative) | 16,133 | — | $0 | Form 4 |
| 2026-01-20 | REED JAN STERN | Director | Grant / award / vesting | 22,214 | — | — | Form 4 |
| 2026-01-20 | Crowe Suzanne | Director | Grant / award / vesting (derivative) | 16,133 | — | $0 | Form 4 |
| 2026-01-20 | Crowe Suzanne | Director | Grant / award / vesting | 22,214 | — | — | Form 4 |
| 2026-01-20 | COOK JEREMY CURNOCK | Director | Grant / award / vesting (derivative) | 16,133 | — | $0 | Form 4 |
| 2026-01-20 | COOK JEREMY CURNOCK | Director | Grant / award / vesting | 22,214 | — | — | Form 4 |
| 2026-01-20 | Tarnoff Michael E | Director | Grant / award / vesting (derivative) | 16,133 | — | $0 | Form 4 |
| 2026-01-20 | Tarnoff Michael E | Director | Grant / award / vesting | 22,214 | — | — | Form 4 |
| 2026-01-20 | Woody Joseph Fralin | Director | Grant / award / vesting (derivative) | 16,133 | — | $0 | Form 4 |
| 2026-01-20 | Woody Joseph Fralin | Director | Grant / award / vesting | 22,214 | — | — | Form 4 |
| 2026-01-20 | McNamara Robert | Director | Grant / award / vesting (derivative) | 16,133 | — | $0 | Form 4 |
| 2026-01-20 | McNamara Robert | Director | Grant / award / vesting | 22,214 | — | — | Form 4 |
| 2026-01-05 | Woody Joseph Fralin | Director | Grant / award / vesting (derivative) | 29,446 | — | $0 | Form 4 |
| 2026-01-05 | Woody Joseph Fralin | Director | Grant / award / vesting | 40,547 | — | — | Form 4 |
| 2025-08-06 | Tarnoff Michael E | Director | Grant / award / vesting (derivative) | 19,063 | — | $0 | Form 4 |
| 2025-08-06 | Tarnoff Michael E | Director | Grant / award / vesting | 26,250 | — | — | Form 4 |
Ask the chat about RCEL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AVITA Medical, Inc. (RCEL).
Last updated 2026-06-12 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.